Literature DB >> 27130651

What is "the patient perspective" in patient engagement programs? Implicit logics and parallels to feminist theories.

Paula Rowland1, Sarah McMillan2, Patti McGillicuddy2, Joy Richards2.   

Abstract

Public and patient involvement (PPI) in health care may refer to many different processes, ranging from participating in decision-making about one's own care to participating in health services research, health policy development, or organizational reforms. Across these many forms of public and patient involvement, the conceptual and theoretical underpinnings remain poorly articulated. Instead, most public and patient involvement programs rely on policy initiatives as their conceptual frameworks. This lack of conceptual clarity participates in dilemmas of program design, implementation, and evaluation. This study contributes to the development of theoretical understandings of public and patient involvement. In particular, we focus on the deployment of patient engagement programs within health service organizations. To develop a deeper understanding of the conceptual underpinnings of these programs, we examined the concept of "the patient perspective" as used by patient engagement practitioners and participants. Specifically, we focused on the way this phrase was used in the singular: "the" patient perspective or "the" patient voice. From qualitative analysis of interviews with 20 patient advisers and 6 staff members within a large urban health network in Canada, we argue that "the patient perspective" is referred to as a particular kind of situated knowledge, specifically an embodied knowledge of vulnerability. We draw parallels between this logic of patient perspective and the logic of early feminist theory, including the concepts of standpoint theory and strong objectivity. We suggest that champions of patient engagement may learn much from the way feminist theorists have constructed their arguments and addressed critique.

Entities:  

Keywords:  health service organizations; patient engagement; policy; standpoint theory; strong objectivity

Mesh:

Year:  2016        PMID: 27130651     DOI: 10.1177/1363459316644494

Source DB:  PubMed          Journal:  Health (London)        ISSN: 1363-4593


  8 in total

1.  Three Sides to Every Story: Preparing Patient and Family Storytellers, Facilitators, and Audiences.

Authors:  Lisa Hawthornthwaite; Taylor Roebotham; Lauren Lee; Mim O'dowda; Lorelei Lingard
Journal:  Perm J       Date:  2018

2.  Metaphors of organizations in patient involvement programs: connections and contradictions.

Authors:  Paula Rowland; Carol Fancott; Julia Abelson
Journal:  J Health Organ Manag       Date:  2021-03-30

3.  Using qualitative Health Research methods to improve patient and public involvement and engagement in research.

Authors:  Danielle E Rolfe; Vivian R Ramsden; Davina Banner; Ian D Graham
Journal:  Res Involv Engagem       Date:  2018-12-13

4.  Setting the research agenda for living with and beyond cancer with comorbid illness: reflections on a research prioritisation exercise.

Authors:  D Cavers; S Cunningham-Burley; E Watson; E Banks; C Campbell
Journal:  Res Involv Engagem       Date:  2020-04-29

5.  Challenges of Patient Engagement in an HIV Clinical Research Program: A Qualitative Analysis of Stakeholder Accounts.

Authors:  David Lessard; Kim Engler; Serge Vicente; Martin Bilodeau; Bertrand Lebouché
Journal:  J Patient Exp       Date:  2020-11-25

6.  Reconceptualizing the Family to Improve Inclusion in Childhood Disability Research and Practice.

Authors:  Michelle Phoenix; Meaghan Reitzel; Rachel Martens; Jeanine Lebsack
Journal:  Front Rehabil Sci       Date:  2021-09-10

7.  Patient advocate perspectives on involvement in HTA: an international snapshot.

Authors:  Anna Mae Scott; Janet L Wale
Journal:  Res Involv Engagem       Date:  2017-01-10

8.  Perceptions of people with respiratory problems on physician performance evaluation-A qualitative study.

Authors:  Carolin Sehlbach; Marjan J B Govaerts; Sharon Mitchell; Truus G J Teunissen; Frank W J M Smeenk; Erik W Driessen; Gernot G U Rohde
Journal:  Health Expect       Date:  2019-11-20       Impact factor: 3.377

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.